HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹442 Cr | ₹522 Cr | ₹550 Cr | ₹442 Cr | ₹438 Cr |
What is the latest Sundry Debtors ratio of HIKAL ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹442 Cr |
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹550 Cr |
| Mar2023 | ₹442 Cr |
| Mar2022 | ₹438 Cr |
How is Sundry Debtors of HIKAL Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹442 Cr | -15.47 | |
| Mar2025 | ₹522 Cr | -5.07 | |
| Mar2024 | ₹550 Cr | 24.56 | |
| Mar2023 | ₹442 Cr | 0.93 | |
| Mar2022 | ₹438 Cr | - | |
Compare Sundry Debtors of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,631.8 Cr | -0.5% | -13.4% | -16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.5% |
-13.4% |
-16.7% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses